Skip to main content

Prescription Assessment

  • Chapter
Practical Pharmaceutics
  • 7816 Accesses

Abstract

Upon receipt of a request from a prescriber for a pharmacy preparation, the pharmacist must decide whether the request is appropriate and reasonable, and judge the level of risk associated with proceeding with the request. The pharmacist must also consider the risks of not supplying a medicine which may lead to the patient not receiving treatment. Further discussion with the medical team may be needed. This chapter approaches the risk assessment of the prescription in a structured way, referring to procedures and forms from different countries. The assessment also includes the feasibility of producing a preparation of appropriate pharmaceutical quality and with all necessary clinical information.

Pharmacy legislation defines the framework in which pharmacists can prepare medicines, however there are other legislative and quality frameworks that they must be aware of if other categories of products are requested, such as biocides, medical devices, or placebo’s, or agents used for euthanasia Veterinary and homeopathic medicines are also dealt with, as are raw materials, especially hazardous materials and precursors.

Based upon the chapter Beoordeling recept by André Wissenburg en Frits Boom in the 2009 edition of Recepteerkunde.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Notes

  1. 1.

    Contribution by Herman Woerdenbag, Groningen, The Netherlands.

References

  1. Roman MJ, Dinh A (2001) A 1,000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder. Pediatrics 108(2):471–472

    Article  Google Scholar 

  2. Anon (1998) Baby dies after peppermint water prescription for colic. Pharm J 260:768

    Google Scholar 

  3. Plausibilitätsprüfung für Rezepturarzneimittel, Beispiel. Tabellen für die Rezeptur. Fassung 2013. Deutscher Arzneimittel-Codex/Neues Rezeptur-Formularium (NRF). Govi-Verlag Pharmazeutischer Verlag GmbH Eschborn. Deutscher Apotheker Verlag Stuttgart

    Google Scholar 

  4. Bouwman Y (2013) Risk assessment forms for pharmacy preparation. Eur J Hosp Pharm 20:A58. doi:10.1136/ejhpharm-2013-000276.161

    Article  Google Scholar 

  5. Commission implementing Directive 2012/52/EU of 20 December 2012 laying down measures to facilitate the recognition of medical prescriptions issued in another Member State. Official Journal of the European Union. 22.12.2012. L 356/68, and Annex L 356/70. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:356:0068:0070:EN:PDF. Accessed 18 Sept 2014

  6. Kinderformularium. Nederlands Kenniscentrum Farmacotherapie bij kinderen. http://www.kinderformularium.nl. Accessed 7 Jul 2014

  7. Pharmazeutischen Laboratorium des Neuen Rezeptur-Formulariums. Formelsammlung für Ärzte. 6te Auflage 2012. Govi-Verlag Pharmazeutischer Verlag GmbH, Eschborn

    Google Scholar 

  8. Medicines for Children Research Network U.K. http://www.medicinesforchildren.org.uk

  9. van der Sijs H, Guchelaar HJ (2002) Formulas for calculating body surface area. Ann Pharmacother 36:345–346

    Article  PubMed  Google Scholar 

  10. BNF for Children. BMJ Group. http://www.bnf.org. Accessed 7 Jul 2014

  11. Alldred DP, Barber N, Buckle P, Carpenter J, Dickinson R, Franklin BD (2009) Care home use of medicines study (CHUMS). Medication errors in nursing and residential care homes–prevalence, consequences, causes and solutions. Report to the Patient Safety Research Portfolio, Dept of Health

    Google Scholar 

  12. Single Convention on Narcotic Drugs, 1961, as amended by the Protocol amending the Single Convention on Narcotic Drugs, 1961; United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. 1988. https://www.unodc.org/pdf/convention_1961_en.pdf. Accessed 18 Sept 2014

  13. Veitch NC, Smith M, Barnes J, Anderson LA, Phillipson JD (2013) Herbal medicines, 4th edn. Pharmaceutical Press, London

    Google Scholar 

  14. Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. http://eur-lex.europa.eu/

  15. European Medicines Agency. Human regulatory. Herbal products. http://www.ema.europa.eu. Accessed 7 Jul 2014

  16. Lau HS, Riezebos J, Abas V, Porsius AJ, De Boer A (2000) A nation-wide study on the practice of euthanasia and physician-assisted suicide in community and hospital pharmacies in The Netherlands. Pharm World Sci 22(1):3–9

    Article  CAS  PubMed  Google Scholar 

  17. Veterinary Medicines Guidance Note No.13 Guidance on the use of cascade. http://www.vmd.defra.gov.uk/pdf/vmgn/VMGNote13.pdf. Accessed 7 Jul 2014

  18. Medical Devices Directive 93/42/EEC. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1993L0042:20071011:EN:PDF. Accessed 7 Jul 2014

  19. Basic information about the European Directive 93/42/EEC on medical devices. www.mdc-ce.de/downloads/040100_06_e.pdf. Accessed 16 Mar 2013

  20. Uhlenbrock S, Bichsel G (2006) Trinatriumcitratlösung zur Blockade von Hämodialyse-Kathetern. Krankenhauspharmazie 27:144–154

    Google Scholar 

  21. European Commission, DG Health and Consumers, Public health, Medical devices. http://ec.europa.eu/health/medical-devices/index_en.htm. Accessed 7 Jul 2014

  22. Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:1998:123:0001:0063:en:PDF. Accessed 18 Sept 2014

  23. Regulation (EC) No 273/2004 of the European Parliament of 11 February 2004 on drug precursors; Council Regulation (EC) No 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Community and third countries in drug precursors

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Lowey .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 KNMP and Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lowey, A., Melhorn, S. (2015). Prescription Assessment. In: Bouwman-Boer, Y., Fenton-May, V., Le Brun, P. (eds) Practical Pharmaceutics. Springer, Cham. https://doi.org/10.1007/978-3-319-15814-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15814-3_2

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15813-6

  • Online ISBN: 978-3-319-15814-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics